Orthofix (OFIX) grants options and RSUs to operations head
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Orthofix Medical Inc. executive Aviva McPherron, President of Global Operations & Quality, received equity awards on the form’s grant date. She was granted 54,656 stock options with an exercise right and 23,024 shares of common stock in the form of restricted stock units, both at a stated price of $0.00 per share.
The options and restricted stock units each vest in three equal one-third installments on the first, second, and third anniversaries of the grant date. After these awards, she directly holds 70,412 shares of common stock, which includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix’s Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
McPherron Aviva
Role
Pres, Global Ops & Qual
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 54,656 | $0.00 | -- |
| Grant/Award | Common Stock | 23,024 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 54,656 shares (Direct);
Common Stock — 70,412 shares (Direct)
Footnotes (1)
- Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. Includes 37,557 previously reported restricted stock units and 1,066 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.
FAQ
What insider transaction was reported for Orthofix Medical (OFIX)?
Aviva McPherron reported equity awards from Orthofix Medical. She received 54,656 employee stock options and 23,024 shares of common stock as restricted stock units, with all awards granted at a stated price of $0.00 per share according to the Form 4 filing.
Who is Aviva McPherron in the Orthofix Medical (OFIX) Form 4 filing?
Aviva McPherron is identified as Orthofix Medical’s President, Global Operations & Quality. The Form 4 shows she received grants of stock options and restricted stock units, increasing her directly held common stock position to 70,412 shares following the reported transactions.
How many stock options did Aviva McPherron receive from Orthofix (OFIX)?
She was granted 54,656 employee stock options. The filing states these options vest and become exercisable in three equal one-third installments on the first, second, and third anniversaries of the grant date, aligning her potential equity benefits with a multi-year timeframe.
What restricted stock unit award did Orthofix Medical (OFIX) grant to Aviva McPherron?
She received 23,024 shares of common stock in the form of restricted stock units. These restricted stock units vest in three equal one-third tranches on each of the first, second, and third anniversaries of the grant date, as approved by the board committee.
How do Aviva McPherron’s Orthofix (OFIX) awards vest over time?
Both the stock options and restricted stock units vest over three years. One-third of the underlying shares vests on each of the first, second, and third anniversaries of the grant date, creating a structured, multi-year vesting schedule tied to continued service.